TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Janet E. Murphy, Jennifer Yon-Li Wo, Cristina Ferrone, Wenqing Jiang, Beow Y. Yeap, Lawrence Scott Blaszkowsky, Eunice Lee Kwak, Jill N. Allen, Jeffrey W. Clark, Jason Edward Faris, Andrew X. Zhu, Lipika Goyal, Harvey J. Mamon, Keith D Lillemoe, David P. Ryan, Thomas F. DeLaney, Carlos Fernandez-del Castillo, Yves Boucher, Theodore S. Hong
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598367490